1. Home
  2. EHTH
  3. Earnings

AI Earnings Predictions for eHealth Inc. (EHTH)

Machine learning predictions based on historical earnings data and price patterns

Latest Prediction

SELL

1-Day Prediction

-7.34%

$0.54

0% positive prob.

5-Day Prediction

-10.01%

$0.52

0% positive prob.

20-Day Prediction

-12.76%

$0.51

0% positive prob.

Price at prediction: $0.58 Confidence: 100.0% Model AUC: 1.0000 Quarter: Q3 2026

Historical Earnings Predictions

Quarter Signal 1D Return 5D Return 20D Return Confidence Actual 5D
Q3 2026 SELL -7.34% -10.01% -12.76% 100.0% Pending
Q2 2026 BUY +4.97% +13.92% +3.96% 99.8% -15.79%
Q1 2026 SELL -6.99% -9.68% -9.74% 100.0% -7.50%
Q4 2025 BUY +3.91% +10.95% +3.12% 57.2% -13.23%

Earnings Transcripts

SEC 8-K filings with transcript text

View All
2026
Q3

Q3 2026 Earnings

8-K SELL

Nov 4, 2026 · 100% conf.

AI Prediction SELL

1D

-7.34%

$0.54

Act: -18.07%

5D

-10.01%

$0.52

20D

-12.76%

$0.51

Price: $0.58 Prob +5D: 0% AUC: 1.000
0001333493-26-000044

EX-99.1

2 exhibit9912026q3earningsre.htm

EX-99.1

Document

eHealth, Inc. Announces Third Quarter 2026 Results

Significant improvement in operating cash flow

AEP preparations successfully completed

Lifetime Advisory Model demonstrates positive early impact on retention and cross-sell rates

INDIANAPOLIS — November 4, 2026 — eHealth, Inc. (Nasdaq: EHTH), a leading private online health insurance marketplace, today announced its financial results for the third quarter ended September 30, 2026.

CEO Comments

“Our third-quarter results were in line with our expectations and demonstrate continued progress against our key priorities for 2026,” said Derrick Duke, Chief Executive Officer of eHealth. “Through the first nine months of the year, we improved operating cash flow by 85% year over year while implementing our lifetime advisory model and meaningfully reducing our cost structure. We entered AEP with a well-prepared organization and a differentiated consumer brand, and we are encouraged by the strong consumer demand we are seeing at attractive lead costs. The most important weeks of AEP are still ahead, and our team is focused on execution.”

Q3 2026 Key Financial Results

Total RevenueGAAP Net Income (Loss) Adjusted EBITDA(1) Operating Cash Flow

$21.3M

$(35.9)M

$(39.9)M

$(11.2)M

vs $53.9M

vs $(31.7)M

vs $(34.0)M

vs $(25.3)M

Comparisons above reflect the comparable metrics from the three months ended September 30, 2025.

Cash, Cash Equivalents & Short-Term Marketable SecuritiesCommissions Receivable

$88.1M

$970.6M

Q3 2026 Key Highlights and Commentary

■Total revenue declined 60% year-over-year, in line with our strategy of reducing variable marketing spend outside of major enrollment periods and focusing benefit advisors on existing member engagement.

■Q3 2026 positive net adjustment revenue of $1.4 million compared to $12.2 million in prior year.

■Lifetime advisory model showed encouraging early results including improved 90-day retention for our Q2 2026 Medicare Advantage enrollment cohort and Q3 2026 ancillary product cross-sell rates nearly doubling compared to prior year.

■Total operating costs and expenses decreased 29% to $67.6 million compared to $95.4 million in prior year.

■Total marketing and advertising expense declined 55% year-over-year; Medicare segment variable marketing and advertising expense declined 73% year-over-year.

■On track to achieve more than $60.0 million in annual variable spend reductions and approximately $30.0 million in annual fixed cost savings compared to prior year.

■Q3 2026 operating cash flow improved by $14.1 million, or 56%, year-over-year, resulting in year-to-date operating cash flow of $19.6 million, an improvement of 85% year-over-year.

■Commissions receivable balance as of September 30, 2026 represents 7% growth from September 30, 2025.


Note: See the tables at the end of this press release for a reconciliation of our GAAP financial measures to our non-GAAP financial measures for the relevant periods and footnote (1) on page 14 at the end of this press release for definitions of our non-GAAP financial measures. Additionally, see accompanying footnotes on page 14 for additional definitions.

1

2026 Guidance

Based on information available as of November 4, 2026, we are reiterating guidance for the full year ending December 31, 2026. These expectations are forward-looking statements and we assume no obligation to update these statements. Actual results may be materially different and are affected by the risk factors and uncertainties identified in this press release and in eHealth’s annual and quarterly reports filed with the Securities and Exchange Commission.

The following guidance is for the full year ending December 31, 2026:

•Total revenue is expected to be in the range of $405.0 million to $445.0 million.

•GAAP net income is expected to be in the range of $8.0 million to $25.0 million.

•Adjusted EBITDA(1) is expected to be in the range of $55.0 million to $75.0 million.

•Operating cash flow is expected to be in the range of $(10.0) million to $12.0 million.

The above guidance includes the expected impact of positive net adjustment revenue which has been updated to be in the range of $17 million to $20 million to reflect the Q3 2026 positive net adjustment revenue, compared to the previous range of $16 million to $20 million.


Note: See accompanying footnotes on page 14.

Webcast and Conference Call Information

A webcast and conference call will be held today, Wednesday, November 4, 2026 at 5:00 p.m. Eastern Time. Individuals interested in listening to the conference call may do so by dialing (833) 461-5787. The participant passcode is 542521622. The live and archived webcast of the call will also be available under “Events & Presentations” on the Investor Relations page of our website at https://ir.ehealthinsurance.com.

About eHealth, Inc.

For nearly 30 years, eHealth, Inc. has helped millions of American

2026
Q2

Q2 2026 Earnings

8-K BUY

Aug 4, 2026 · 100% conf.

AI Prediction BUY

1D

+4.97%

$1.52

Act: -13.03%

5D

+13.92%

$1.65

Act: -15.79%

20D

+3.96%

$1.51

Price: $1.45 Prob +5D: 100% AUC: 1.000
0001333493-26-000033

EX-99.1

2 exhibit9912026q2earningsre.htm

EX-99.1

Document

eHealth, Inc. Announces Second Quarter 2026 Results

Lifetime Advisory Model increasing member engagement

On track to achieve meaningful YoY improvements in annual operating cash flow

INDIANAPOLIS — August 4, 2026 — eHealth, Inc. (Nasdaq: EHTH), a leading private online health insurance marketplace, today announced its financial results for the second quarter ended June 30, 2026.

CEO Comments

“Second quarter results were in line to slightly above our expectations and reflect the deliberate choices we made going into 2026. We entered the year with a strategy centered on three priorities: building our lifetime advisory model, materially improving our cash flow profile, and making targeted investments in long-term growth opportunities such as ICHRA. In Q2, we saw encouraging early results from our lifetime advisory model including material growth in ancillary cross-sell rates and other key member engagement metrics. As we enter the second half of 2026, eHealth remains on track to achieve our financial targets including meaningful year-over-year improvements in operating cash flow. Importantly, we are building the operating and financial foundation necessary to return the business to sustainable growth beginning in 2027.”– Derrick Duke, Chief Executive Officer

Q2 2026 Key Financial Results

Total RevenueGAAP Net Income (Loss) Adjusted EBITDA(1) Operating Cash Flow

$33.6M

$(23.6)M

$(21.8)M

$(5.0)M

vs $60.8M

vs $(17.4)M

vs $(14.1)M

vs $(41.2)M

Comparisons above reflect the comparable metrics from the three months ended June 30, 2025.

Cash, Cash Equivalents & Short-Term Marketable SecuritiesCommissions Receivable

$101.0M

$1.0B

Q2 2026 Key Highlights and Commentary

■Total revenue declined 45% year-over-year reflecting lower Medicare enrollment volume, consistent with our strategy to reduce variable marketing spend outside of major enrollment periods and focus benefit advisors on existing member engagement.

■Q2 2026 positive net adjustment revenue of $7.6 million compared to $17.8 million in prior year.

■Launched lifetime advisory model with a goal of deepening member-advisory relationships and driving increased engagement, retention and member lifetime values.

■Q2 2026 ancillary product cross-sell rates doubled compared to prior year and observed improvements in additional member engagement metrics, reflecting early success of new operating model.

■Total operating costs and expenses decreased 27% to $61.0 million compared to $83.8 million in prior year driven by cost reduction program implemented in January.

■On track to achieve more than $60.0 million in annual variable spend reductions and approximately $30.0 million in annual fixed cost savings compared to prior year.

■Operating cash flow improved by $36.2 million year-over-year, reflecting disciplined expense management and targeted cost reduction initiatives.

■Commissions receivable balance as of June 30, 2026 represents 10% growth from June 30, 2025.

■Advanced efforts towards building ICHRA business, including developing our pipeline, expanding strategic partnerships, strengthening broker relationships and continuing to refine our operating model.


Note: See the tables at the end of this press release for a reconciliation of our GAAP financial measures to our non-GAAP financial measures for the relevant periods and footnote (1) on page 14 at the end of this press release for definitions of our non-GAAP financial measures. Additionally, see accompanying footnotes on page 14 for additional definitions.

1

2026 Guidance

Based on information available as of August 4, 2026, we are reiterating guidance for the full year ending December 31, 2026. These expectations are forward-looking statements and we assume no obligation to update these statements. Actual results may be materially different and are affected by the risk factors and uncertainties identified in this press release and in eHealth’s annual and quarterly reports filed with the Securities and Exchange Commission.

The following guidance is for the full year ending December 31, 2026:

•Total revenue is expected to be in the range of $405.0 million to $445.0 million.

•GAAP net income is expected to be in the range of $8.0 million to $25.0 million.

•Adjusted EBITDA(1) is expected to be in the range of $55.0 million to $75.0 million.

•Operating cash flow is expected to be in the range of $(10.0) million to $12.0 million.

The above guidance includes the expected impact of positive net adjustment revenue which has been updated to be in the range of $16 million to $20 million to reflect the Q2 2026 positive net adjustment revenue, compared to the previous range of $8 to $20 million.


Note: See accompanying footnotes on page 14.

Webcast and Conference Call Information

A webcast and conference call will be held today, Tuesday, August 4, 2026 at 5:00 p.m. Eastern Time. Individuals interested in list

2026
Q1

Q1 2026 Earnings

8-K SELL

May 6, 2026 · 100% conf.

AI Prediction SELL

1D

-6.99%

$1.86

Act: -7.00%

5D

-9.68%

$1.81

Act: -7.50%

20D

-9.74%

$1.81

Act: -21.00%

Price: $2.00 Prob +5D: 0% AUC: 1.000
0001333493-26-000025

EX-99.1

2 exhibit9912026q1earningsre.htm

EX-99.1

Document

eHealth, Inc. Announces First Quarter 2026 Results

Q1 2026 results ahead of expectations

Strong Medicare segment profitability and operating expense improvements YoY

Launches lifetime advisory model and final expense insurance offering

On track to reduce total FY 2026 operating costs by approximately $90M

INDIANAPOLIS — May 6, 2026 — eHealth, Inc. (Nasdaq: EHTH), a leading private online health insurance marketplace, today announced its financial results for the first quarter ended March 31, 2026.

CEO Comments

“We’re pleased with our first quarter results, which came in ahead of expectations, driven by stronger than anticipated enrollment volume at favorable acquisition costs. During the quarter, we made meaningful progress towards our FY 2026 strategic initiatives, including implementing targeted cost reductions and completing critical build and readiness work for initiatives that launched in April. Most notably, we prepared for the rollout of our lifetime advisory model and the introduction of our new final expense insurance product, continuing to strengthen our ability to serve consumers navigating an increasingly complex healthcare landscape.”– Derrick Duke, Chief Executive Officer

Results Overview

■Q1 2026 total revenue of $88.0 million decreased 22% compared to Q1 2025 total revenue of $113.1 million, reflecting lower Medicare approved members, consistent with our strategy to reduce variable and fixed expenses in fiscal 2026 and focus demand generation on our more profitable marketing channels.

■Q1 2026 positive net adjustment revenue of $8.0 million compared to $10.5 million in Q1 2025.

■Q1 2026 constrained lifetime value (“LTV”) of commissions improved across all Medicare products year-over-year, reflecting:

■a 3% increase in Medicare Advantage (“MA”) plans;

■a 19% increase in Medicare Supplement plans; and

■a 78% increase in Medicare Part D plans.

■Q1 2026 total operating costs and expenses decreased 16% to $90.9 million compared to $108.3 million in Q1 2025.

■Variable marketing spend within our Medicare segment declined 45% year-over-year.

■Q1 2026 non-GAAP total operating costs and expenses(1) decreased 21% year-over-year.

■Significant expansion in Q1 2026 Medicare segment gross margin to 41% from 34% in Q1 2025.

■Q1 2026 Medicare unit economics improved year-over-year, driven by higher MA constrained LTV of commissions and a 10% reduction in total acquisition cost per MA-equivalent approved member.

■ Medicare LTV-to-CAC ratio(8) of 1.4x, up from 1.2x in Q1 2025.

■Q1 2026 GAAP net loss of $4.7 million compared to Q1 2025 GAAP net income of $2.0 million primarily due to Q1 2026 restructuring charges of $6.4 million.

■ Q1 2026 GAAP net loss margin of 5% compared to Q1 2025 GAAP net income margin of 2%.

■Q1 2026 adjusted EBITDA(1) of $9.0 million declined 28% compared to Q1 2025 adjusted EBITDA(1) of $12.5 million.

■Q1 2026 adjusted EBITDA margin(1) of 10% compared to Q1 2025 adjusted EBITDA margin(1) of 11%.

■Operating cash flow of $35.8 million for the three months ended March 31, 2026; on-track to achieve operating cash flow guidance for FY 2026.

■Cash, cash equivalents and short-term marketable securities of $110.8 million as of March 31, 2026.

■Commissions receivable balance of $1.0 billion as of March 31, 2026.


Note: See the tables at the end of this press release for a reconciliation of our GAAP financial measures to our non-GAAP financial measures for the relevant periods and footnote (1) on page 14 at the end of this press release for definitions of our non-GAAP financial measures. Additionally, see accompanying footnotes on page 14 for additional definitions.

1

2026 Guidance

Based on information available as of May 6, 2026, we are reiterating guidance for the full year ending December 31, 2026. These expectations are forward-looking statements and we assume no obligation to update these statements. Actual results may be materially different and are affected by the risk factors and uncertainties identified in this press release and in eHealth’s annual and quarterly reports filed with the Securities and Exchange Commission.

The following guidance is for the full year ending December 31, 2026:

•Total revenue is expected to be in the range of $405.0 million to $445.0 million.

•GAAP net income is expected to be in the range of $8.0 million to $25.0 million.

•Adjusted EBITDA(1) is expected to be in the range of $55.0 million to $75.0 million.

•Operating cash flow is expected to be in the range of $(10.0) million to $12.0 million.

The above guidance includes the expected impact of positive net adjustment revenue which has been updated to be in the range of $8 million to $20 million to reflect the Q1 2026 positive net adjustment revenue, compared to the previous range of $0 to $20 million.


Note: See accompanying footnotes on page 14.

Webcast and Conference Call Information

A

About eHealth Inc. (EHTH) Earnings

This page provides eHealth Inc. (EHTH) earnings call transcripts from SEC 8-K filings along with AI-powered predictions for post-earnings price movements. Our machine learning models analyze historical earnings data, pre-earnings price patterns, volume changes, and volatility to predict 1-day, 5-day, and 20-day returns after each earnings release.

Earnings transcripts are sourced directly from SEC EDGAR filings. Predictions are generated using gradient boosting models trained on EHTH's historical earnings reactions. All predicted returns are shown as percentages, and predicted prices are calculated from the closing price at the time of prediction. Past performance does not guarantee future results.

Share on Social Networks: